nav_top

Username:
Password:

Remember Me
Forgot Password

Benefits of Membership
Search By Keyword Or Search By

Getting to Goal for Patients with Type 2 Diabetes: Emerging Strategies for Pharmacists

Release Date: June 26, 2009
Expiration Date: June 26, 2010

SPONSORSHIP
This activity is jointly sponsored by Postgraduate Institute for Medicine and Impact Education, LLC.


COMMERCIAL SUPPORT

This activity is supported by an educational grant from Takeda Pharmaceuticals North America, Inc.

TARGET AUDIENCE
This complimentary continuing education activity has been designed to meet the educational needs of community-based practicing pharmacists and clinic-based pharmacists.

STATEMENT OF NEED
Considering the significant burden of illness imposed by diabetes, pharmacy professionals should consider what additional steps can be taken to prevent the complications related to the disease, thus slowing the rise in costs. This activity will instruct pharmacy professionals on the benefits of early diagnosis and aggressive management of type 2 diabetes and its related complications. Recent findings as well as emerging evidence on the use of current and emerging anti-diabetics will be evaluated on their mechanism of action, safety, and appropriate therapeutic positioning including combination therapy and monotherapy. The impact of clinical inertia on patients with type 2 diabetes will be explored and a subsequent discussion will occur on the overall risks versus benefits of various treatment options on patient outcomes. This activity will also provide specific educational instruction for pharmacy professionals to obtain the knowledge, competency, and skills needed to improve overall patient outcomes, including adherence to therapies, for the treatment of type 2 diabetes.

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:

  • Outline current goals and guidelines of glucose-lowering therapy
  • Define the impact of clinical inertia on the benefits of early diagnosis and aggressive management of type 2 diabetes and its related complications
  • Review the evolving evidence on current and emerging treatment options for type 2 diabetes
  • Recall diabetic medication adherence strategies that can be implemented by pharmacists

ESTIMATED TIME TO COMPLETE THE EDUCATIONAL ACTIVITY
1.25 Hours

ACCREDITATION STATEMENTS
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Impact Education, LLC. PIM is accredited by the ACCME to provide continuing medical education for physicians.

Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Postgraduate Institute for Medicine designates this continuing education activity for 1.25 contact hours (0.125 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number: 809-999-08-266-H01-P)

If you participated in Universal Activity Number: 809-999-08-266-L01-P, you are not eligible to receive credit for this activity.

FACULTY INFORMATION

Susan Butterworth, PhD, MS
(Click on faculty name to view full biography)
Vice President, Health Management Services, Health Future, LLC
Associate Professor, Oregon Health and Science University
Disclosure – No financial relationship to disclose related to the topic of this activity.

Susan Cornell, BS, PharmD, CDE, FAPhA, FAADE
(Click on faculty name to view full biography)
Assistant Director of Experiential Education
Assistant Professor of Pharmacy Practice
Midwestern University Chicago College of Pharmacy
Disclosure – Receives non-CME fees from Johnson & Johnson Institute.

Tommy Johnson, PharmD, CDE
(Click on faculty name to view full biography)
Clinical Associate Professor
Clinical Administrative Pharmacy
The University of Georgia College of Pharmacy
Disclosure – Receives consulting fees from Can Am Care, Res Med, and APhA.

Curtis Triplitt, PharmD, CDE
(Click on faculty name to view full biography)
Texas Diabetes Institute
Assistant Professor of Medicine/Division of Diabetes
University of Texas Health Science Center at San Antonio
Disclosure – Receives consulting fees from Amylin; receives non-CME fees from Amylin/Eli Lilly, Novartis, and Takeda Pharmaceuticals.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Planner or Manager Reported Financial Relationship
Steve Casebeer, MBA No financial interest/relating to the topic of this activity
The following PIM planners and managers, Linda Graham, RN, BSN, BA, Jan Hixon, RN, BSN, MA, Trace Hutchison, PharmD, Julia Kirkwood, RN, BSN and Jan Schultz, RN, MSN, CCMEP hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

METHOD OF PARTICIPATION IN THE LEARNING PROCESS
There are no fees for participating and receiving CME/CE credit for this activity. During the period June 2009 through June 2010, participants must:

  • Read the learning objectives and faculty disclosures.
  • Study the educational activity.
  • Complete the post-test by recording the best answer to each question.
  • Complete the evaluation form.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better. You may re-take the post-test up to three times. Upon successful completion, a statement of credit will be available immediately.

FEE
There is no fee for this educational activity.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), Impact Education, LLC (IE) and Takeda Pharmaceuticals North America, Inc. (TPNA) do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, IE and TPNA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

For questions about the accreditation of this activity, please contact Postgraduate Institute for Medicine at information@pimed.com.

SOFTWARE REQUIREMENTS
PC
Microsoft Windows 2000 SE or above.
Flash Player Plugin (v8 or greater)
Internet Explorer (v5.5 or greater), or Firefox
Adobe Acrobat Reader*

MAC
MAC OS 10.2.8
Flash Player Plugin (v8 or greater)
Safari
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh.

* Required to view printable (PDF) version of the lesson.


Select a Profession to Continue: